Clinical Trial Update: Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)

View source ↗

Summary

An observational study completed to characterize real-world clinical outcomes in relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED